Are Zenlabs Ethica Ltd latest results good or bad?
2026-02-07 19:21:30Zenlabs Ethica Ltd's latest financial results for Q2 FY26 present a complex picture of operational challenges. The company reported a net profit of ₹0.04 crores, which reflects a sequential improvement of 33.33% from the previous quarter, but shows a significant decline of 20.00% compared to the same quarter last year. Revenue for the same period was ₹12.43 crores, marking an 8.28% increase quarter-on-quarter, yet this is accompanied by a year-on-year decline of 6.89%, indicating ongoing revenue pressures. The profit after tax (PAT) margin remains extremely low at 0.32%, suggesting minimal profitability and a lack of buffer against operational disruptions. Additionally, the return on equity (ROE) has dropped to 2.37%, highlighting severe capital inefficiency and raising concerns about the company's ability to generate adequate returns for shareholders. The operating profit margin also saw compression, dec...
Read full news article
Zenlabs Ethica Q2 FY26: Razor-Thin Margins and Persistent Losses Deepen Investor Concerns
2026-02-07 17:48:11Zenlabs Ethica Ltd., a micro-cap pharmaceutical contract marketing and trading company, reported yet another quarter of anaemic profitability in Q2 FY26, with net profit standing at a meagre ₹0.04 crores on revenues of ₹12.43 crores. The stock, already languishing in bearish territory, has shed 46.54% over the past year and currently trades at ₹19.03, reflecting persistent investor scepticism about the company's ability to generate meaningful returns. With a market capitalisation of just ₹13.00 crores and a concerning pattern of margin compression, the Chandigarh-based firm faces mounting challenges in a competitive pharmaceutical distribution landscape.
Read full news article
Zenlabs Ethica Ltd Valuation Shifts to Fair Amidst Market Pressure
2026-02-02 08:03:04Zenlabs Ethica Ltd, a player in the Diversified Commercial Services sector, has recently undergone a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. Despite this improvement, the company continues to face significant headwinds, reflected in its deteriorating returns and cautious market sentiment. This article analyses the latest valuation metrics, compares them with peers and historical benchmarks, and assesses the implications for investors.
Read full news article
Zenlabs Ethica Ltd Stock Falls to 52-Week Low of Rs.18
2026-02-01 12:43:36Zenlabs Ethica Ltd, a player in the Diversified Commercial Services sector, has touched a new 52-week low of Rs.18 today, marking a significant decline in its stock price amid ongoing challenges reflected in its financial and market performance.
Read full news article
Zenlabs Ethica Ltd Falls to 52-Week Low of Rs.18.01 Amid Continued Underperformance
2026-01-30 11:13:28Zenlabs Ethica Ltd, a player in the Diversified Commercial Services sector, has reached a new 52-week low of Rs.18.01 today, marking a significant decline in its stock price amid persistent underperformance relative to its sector and benchmark indices.
Read full news article
Zenlabs Ethica Ltd Falls to 52-Week Low Amidst Continued Downtrend
2025-12-30 12:02:00Zenlabs Ethica Ltd, a player in the Diversified Commercial Services sector, has touched a new 52-week low of Rs.18.5 today, marking a significant milestone in its ongoing price decline. The stock has been under pressure for several sessions, reflecting persistent challenges in its financial performance and valuation metrics.
Read full news article
Zenlabs Ethica Ltd is Rated Strong Sell
2025-12-26 15:12:32Zenlabs Ethica Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 30 September 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed here represent the company’s current position as of 26 December 2025, providing investors with the latest insights into its performance and prospects.
Read full news article
Zenlabs Ethica Falls to 52-Week Low of Rs.19.15 Amid Prolonged Downtrend
2025-12-18 10:04:53Zenlabs Ethica, a player in the diversified commercial services sector, has reached a new 52-week low of Rs.19.15, marking a significant decline amid a sustained period of negative returns and underperformance relative to its sector and benchmark indices.
Read full news article
Zenlabs Ethica Falls to 52-Week Low of Rs.19.15 Amid Prolonged Downtrend
2025-12-18 10:04:36Zenlabs Ethica, a player in the Diversified Commercial Services sector, touched a new 52-week low of Rs.19.15 today, marking a significant milestone in its ongoing price decline. The stock has experienced a sustained downward trajectory, reflecting a series of challenges over the past year.
Read full news articleBoard Meeting Intimation for Approval Of Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended On 31St December 2025
03-Feb-2026 | Source : BSEZenlabs Ethica Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2026 inter alia to consider and approve Unaudited Financial Results of the Company for the Quarter and Nine months ended 31st December 2025 and any other matter with the permission of the Chairman.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
09-Jan-2026 | Source : BSECompliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the Quarter ended December 31 2025
Closure of Trading Window
29-Dec-2025 | Source : BSEThe Trading window will remain closed for all Directors/Promoters/Designated Persons and their immediate relatives of the company from Thursday 01st January 2026 till 48 hours after declaration of unaudited financial results for the quarter and nine months ended on 31st December2025
Corporate Actions
(07 Feb 2026)
Zenlabs Ethica Ltd has declared 2% dividend, ex-date: 29 Jul 22
No Splits history available
Zenlabs Ethica Ltd has announced 1:20 bonus issue, ex-date: 11 Oct 18
No Rights history available






